Clinical Trial: A Pharmacokinetic Study of HDM1005 Injection at Different Injection Sites

U.S., Sept. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07828197) titled 'A Pharmacokinetic Study of HDM1005 Injection at Different Injection Sites' on Sept. 14.

Brief Summary: The purpose of this study is to evaluate the relative bioavailability of a single subcutaneous injection of HDM1005 solution at different injection sites (upper arm and thigh)by using the abdomen subcutaneous injection as a control.

Study Start Date: Sept. 03

Study Type: INTERVENTIONAL

Condition: Overweight and/or Obesity Healthy Participants

Intervention: DRUG: HDM1005

2.0 mg, SC, single dose

Recruitment Status: ACTIVE_NOT_RECRUITING

Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.

Disclaimer: Curated by HT S...